Data / Form D filings / BRIGHT MINDS BIOSCIENCES INC.
BRIGHT MINDS BIOSCIENCES INC.: Form D filings
BRIGHT MINDS BIOSCIENCES INC., a biotechnology company in New York, NY, filed 14 Form D notices with the SEC between 2020 and 2024. The latest, on November 19, 2024, reports $34.6 million sold of a $34.6 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 19 VESTRY STREET, New York, NY, 10013
- Phone
- (647) 407-2515
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1827401
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | New notice | $34,599,955 | $34,599,955 | 13 | Nov 4, 2024 | sec.gov | |
| Oct 22, 2024 | New notice | $12,186 | $0 | $12,186 | 1 | Oct 3, 2024 | sec.gov |
| May 3, 2024 | New notice | $54,160 | $0 | $54,160 | 2 | Mar 22, 2024 | sec.gov |
| Sep 14, 2022 | New notice | $149,784 | $0 | $149,784 | 1 | Sep 6, 2022 | sec.gov |
| Sep 1, 2022 | New notice | $220,329 | $0 | $220,329 | 1 | Aug 30, 2022 | sec.gov |
| May 3, 2022 | New notice | $82,667 | $82,667 | 1 | Feb 11, 2022 | sec.gov | |
| May 3, 2022 | New notice | $59,765 | $59,765 | 1 | Feb 4, 2022 | sec.gov | |
| Jun 25, 2021 | New notice | $623,580 | $0 | $623,580 | 1 | Jun 15, 2021 | sec.gov |
| May 4, 2021 | New notice | $299,815 | $299,815 | 1 | Apr 29, 2021 | sec.gov | |
| Mar 23, 2021 | New notice | $838,699 | $516,175 | $322,524 | 1 | Mar 17, 2021 | sec.gov |
| Nov 17, 2020 | New notice | $1,602 | $1,602 | 17 | Nov 2, 2020 | sec.gov | |
| Nov 17, 2020 | New notice | $680,470 | $680,470 | 12 | Nov 2, 2020 | sec.gov | |
| Oct 7, 2020 | New notice | $218,040 | $218,040 | 1 | Sep 18, 2020 | sec.gov | |
| Oct 6, 2020 | New notice | $280,012 | $140,006 | $140,006 | 1 | Jul 23, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David M Weiner | Director | |
| Jan Torleif Pedersen | Executive Officer, Director | |
| Jeremy M Fryzuk | Director | |
| Nils M Bottler | Director | |
| Ian McDonald | Executive Officer, Director | |
| Ryan Cheung | Executive Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Nov 18, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BRIGHT MINDS BIOSCIENCES INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.